Research News and Research

RSS

Study: Activation of Lhx2 gene promotes hair growth

Activation of the gene Lhx2 leads to increased hair growth. This is shown by Leif Carlsson's research team at Umeå University in Sweden in an article in the latest Web edition of the respected scientific journal PLoS Genetics. The findings partly refute earlier research results in the field.

15 Apr 2010

M2010 to encompass broader spectrum of HIV prevention research

HIV prevention researchers, policy makers and community advocates from more than 35 countries will be in Pittsburgh, May 22-25 to attend the 2010 International Microbicides Conference.

15 Apr 2010

Rush University Medical Center's Orthopedic Building awarded Gold LEED certification

The U.S. Green Building Council has awarded the Orthopedic Building at Rush University Medical Center Gold Leadership in Energy and Environmental Design (LEED) certification. LEED is an internationally recognized green building certification system and the nationally accepted benchmark for the design, construction and operation of high performance green buildings.

15 Apr 2010

EGEE User Forum to highlight role of grid computing techniques in diagnosing cancer and heart diseases

Cancer, heart and circulatory system diseases cause two thirds of all deaths in Europe. Three research projects at this week's Enabling Grids for E-sciencE (EGEE) User Forum in Uppsala, Sweden, are demonstrating ways that modern computing techniques can investigate today's biggest killers.

15 Apr 2010

MU researcher compiles evidence that supports Darwin's theory of sexual selection

In 1871, Charles Darwin sparked debate that continues today when he proposed that human sex differences evolved based on sexual selection. Sexual selection is Darwin's theory that certain physical, mental or psychological traits evolved because they aid in competition among individuals for access to preferred mates or because they are enhancements of traits that help to attract mates.

15 Apr 2010

Rigorous FDA approval process presents problems for percutaneous heart valve device manufacturers

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the rigorous FDA approval process is creating major hurdles for percutaneous heart valve device manufacturers.

15 Apr 2010

FDA: Seven MDIs for treating asthma and COPD to be phased out

The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients.

15 Apr 2010

Researchers develop new method to identify genetic variation in active genes

Researchers at Uppsala University have developed a new method for identifying genetic variation, including mutations, in active genes. Hopes are strong that the method represents an important research tool that will lead to the development of new diagnostic tests.

15 Apr 2010

A renewed effort to reduce global toll of maternal and child deaths

Widespread global use of known and proven maternal and childcare techniques, practices, and therapies could save the lives of millions of women, newborns and children each year, according to a new analysis prepared for a mid-April meeting of world leaders and technical experts on maternal and child health.

15 Apr 2010

BRAMS selected to provide DSP tools to investigate brain plasticity in humans

Sonomax Technologies Inc. has been selected by Montr-al's International Laboratory for Brain, Music and Sound Research to provide miniaturized, real-time, in-ear, digital signal processing devices to investigate experience-dependent brain plasticity in humans.

15 Apr 2010

Synergistic interactions of A2A Agonist and PDE Inhibitors as adjunctive therapy to GC for treating MM

“Glucocorticoids are a key component of combination therapy regimens in multiple myeloma and other hematological cancers. However, glucocorticoid use comes with substantial dose limiting toxicities. The ability to enhance glucocorticoid dependent effects while sparing associated toxicities may have important implications for the treatment of multiple myeloma and other B-cell malignancies”

15 Apr 2010

Targeted therapy MDV3100 is effective for patients with CRPC: Study

An experimental drug is showing promise for the treatment of men with an aggressive form of advanced prostate cancer. A new multicenter study has concluded that the targeted therapy MDV3100 is safe and effective for patients with castration-resistant prostate cancer, known for its poor prognosis and limited treatment options.

15 Apr 2010

ICGC: New era of personalised medicine for cancer patients

Published online today in Nature, a paper authored by over 200 members of the International Cancer Genome Consortium describes the beginnings of a Brave New World, a new era of personalised medicine for cancer patients.

15 Apr 2010

ProCure Proton Therapy Center treats cancer patients with proton therapy technology

The world's first inclined beam treatment room is open and treating patients at the ProCure Proton Therapy Center in Oklahoma City. The third of four treatment rooms at the Oklahoma Center is treating a wide range of tumors with proton therapy, an important alternative to X-ray radiation in treating cancer.

15 Apr 2010

New findings point to potential dysfunctional learning process in chronic pain patients

New research reveals why a stimulus that healthy human subjects perceive as a reward might be processed quite differently in the brains of humans suffering from chronic pain.

15 Apr 2010

Cegedim Dendrite announces global SaaS CRM agreement with UCB

Cegedim Dendrite, the world's leading provider of life-sciences specific Customer Relationship Solutions, has signed a global SaaS CRM agreement with biopharmaceutical company UCB.

15 Apr 2010

Research team to receive AACR Team Science Award

The fourth annual American Association for Cancer Research Team Science Award will be given to Dana-Farber/Harvard Cancer Center Thoracic Oncology Research Team at the AACR 101st Annual Meeting 2010. This research team is comprised of interdisciplinary investigators from the Dana-Farber Cancer Institute, Brigham and Women's Hospital, Massachusetts General Hospital, Beth Israel Deaconess Medical Center and Harvard Medical School.

15 Apr 2010

New findings may aid in developing medications for atherosclerosis and insulin resistance

Scientists from Eastern Virginia Medical School (EVMS) recently presented preliminary research findings that identify a specific gene as a potential new target for treating obesity-related diseases.

15 Apr 2010

Phase II clinical study examining CTT's Calmare pain therapy medical device completed

Competitive Technologies, Inc. announced today that Thomas J. Smith, MD FACP, and co-investigator Patrick J. Coyne, MSN, APRN, FAAN, of Virginia Commonwealth University's Massey Cancer Center have completed their open Phase II clinical study examining CTT's Calmare pain therapy medical device's efficacy treating patients suffering with severe pain from chemotherapy induced peripheral neuropathy.

15 Apr 2010

Albert Einstein College of Medicine receives grant to study link between housing status and cardiovascular health

Albert Einstein College of Medicine of Yeshiva University has been awarded $750,000 by the John D. and Catherine T. MacArthur Foundation to study the impact of housing on the cardiovascular health of Latinos in the Bronx.

15 Apr 2010

Research News and Research

Study: Activation of Lhx2 gene promotes hair growth

M2010 to encompass broader spectrum of HIV prevention research

Rush University Medical Center's Orthopedic Building awarded Gold LEED certification

EGEE User Forum to highlight role of grid computing techniques in diagnosing cancer and heart diseases

MU researcher compiles evidence that supports Darwin's theory of sexual selection

Rigorous FDA approval process presents problems for percutaneous heart valve device manufacturers

FDA: Seven MDIs for treating asthma and COPD to be phased out

Researchers develop new method to identify genetic variation in active genes

A renewed effort to reduce global toll of maternal and child deaths

BRAMS selected to provide DSP tools to investigate brain plasticity in humans

Synergistic interactions of A2A Agonist and PDE Inhibitors as adjunctive therapy to GC for treating MM

Targeted therapy MDV3100 is effective for patients with CRPC: Study

ICGC: New era of personalised medicine for cancer patients

ProCure Proton Therapy Center treats cancer patients with proton therapy technology

New findings point to potential dysfunctional learning process in chronic pain patients

Cegedim Dendrite announces global SaaS CRM agreement with UCB

Research team to receive AACR Team Science Award

New findings may aid in developing medications for atherosclerosis and insulin resistance

Phase II clinical study examining CTT's Calmare pain therapy medical device completed

Albert Einstein College of Medicine receives grant to study link between housing status and cardiovascular health

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News